Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the safety and efficacy of the Nd:YAG 1440 nm wavelength laser for the treatment of primary hyperhidrosis of the axilla.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Cynosure, Inc.
NCT05403710 · Hidradenitis Suppurativa, Hyperhidrosis
NCT06638827 · Hyperhidrosis Primary Focal Palms
NCT05102396 · Hyperhidrosis, Oxybutynin, and more
NCT05805696 · Dermatoses, Vestibulodynia, and more
NCT04159610 · Primary Axillary Hyperhidrosis
Skin Care Physicians
Chestnut Hill, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions